GrowBLOX Sciences, Inc. (GBLX): First of Several P
Post# of 118
Posted On: 09/28/2015 5:26:37 PM
GrowBLOX Sciences, Inc. (GBLX): First of Several Planned Medical Cannabis Cultivation Labs Scheduled for 4Q
GrowBLOX Sciences, a biopharmaceutical company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, today reports that the first of its four planned Cultivation Labs – this one a 30,000-square-foot facility in Las Vegas – is scheduled to open by the end of the fourth quarter. In the news release regarding the upcoming opening, the company posted several pictures of its Cultivation Lab (http://finance.yahoo.com/news/growblox-sciences-announces-first-four-130000171.html).
Packed with cutting-edge technology, the Las Vegas Cultivation Lab will feature fully contained clean room structures equipped with state-of-the-art lighting, air handling, humidity control, CO2 management, irrigation and fertigation. A centralized automated system and remote access controls will operate these important features, enabling for a high level of precision environmental control and monitoring essential for the collection of new data that will be invaluable for the medical cannabis industry.
When it comes to production, at full capacity the Las Vegas Cultivation Lab will produce more than 7,000 pounds of certified medical grade raw material annually. It will feature the precision of a laboratory and the size of a greenhouse. As the first of four planned laboratories and at full capacity, the company projects the Las Vegas Cultivation Lab will generate $10 million-$12 million in revenue per annum.
“Our flagship laboratory, the Las Vegas Cultivation Lab, is only the first of four Cultivation Labs being built. As such, it is the standard bearer for the cutting-edge technological growing of medical grade cannabis, and is a timely address to the problem of inadequate supplies of medical grade cannabis. GrowBLOX Sciences continues to be a frontrunner in the medical cannabis industry — and this is only the beginning of great things to come,” chairman of the board and CEO Craig Ellins stated in the news release.
For more information visit www.growblox.com
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
GrowBLOX Sciences, a biopharmaceutical company with state-of-the-art technologies in plant biology and cultivation designed to produce consistent medicinal cannabis, today reports that the first of its four planned Cultivation Labs – this one a 30,000-square-foot facility in Las Vegas – is scheduled to open by the end of the fourth quarter. In the news release regarding the upcoming opening, the company posted several pictures of its Cultivation Lab (http://finance.yahoo.com/news/growblox-sciences-announces-first-four-130000171.html).
Packed with cutting-edge technology, the Las Vegas Cultivation Lab will feature fully contained clean room structures equipped with state-of-the-art lighting, air handling, humidity control, CO2 management, irrigation and fertigation. A centralized automated system and remote access controls will operate these important features, enabling for a high level of precision environmental control and monitoring essential for the collection of new data that will be invaluable for the medical cannabis industry.
When it comes to production, at full capacity the Las Vegas Cultivation Lab will produce more than 7,000 pounds of certified medical grade raw material annually. It will feature the precision of a laboratory and the size of a greenhouse. As the first of four planned laboratories and at full capacity, the company projects the Las Vegas Cultivation Lab will generate $10 million-$12 million in revenue per annum.
“Our flagship laboratory, the Las Vegas Cultivation Lab, is only the first of four Cultivation Labs being built. As such, it is the standard bearer for the cutting-edge technological growing of medical grade cannabis, and is a timely address to the problem of inadequate supplies of medical grade cannabis. GrowBLOX Sciences continues to be a frontrunner in the medical cannabis industry — and this is only the beginning of great things to come,” chairman of the board and CEO Craig Ellins stated in the news release.
For more information visit www.growblox.com
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.com
(0)
(0)